Calreticulin is an endoplasmic reticulum resident Ca 2؉ -binding chaperone. The importance of the protein is illustrated by embryonic lethality because of impaired cardiac development in calreticulin-deficient mice. The molecular details underlying this phenotype are not understood. In this study, we show that overexpression of activated calcineurin reverses the defect in cardiac development observed in calreticulin-deficient mice and rescues them from embryonic lethality. The surviving mice show no defect in cardiac development but exhibited growth retardation, hypoglycemia, increased levels of serum triacylglycerols, and cholesterol. Reversal of embryonic lethality because of calreticulin deficiency by activated calcineurin underscores the impact of the calreticulin-calcineurin functions on the Ca 2؉ -dependent signaling cascade during early cardiac development. These findings show that calreticulin and calcineurin play fundamental roles in Ca 2؉ -dependent pathways essential for normal cardiac development and explain the molecular basis for the rescue of calreticulin-deficient phenotype.
Calreticulin is an endoplasmic reticulum resident Ca 2ϩ -binding protein that affects endoplasmic reticulum Ca 2ϩ and participates in the folding of proteins (1) . Calreticulin deficiency in mice is embryonically lethal because of impaired cardiac development (2, 3) . Mice homozygous for the calreticulin gene disruption showed a marked decrease in ventricular wall thickness and deep intertrabecular recesses in the ventricular walls (2) . The molecular details underlying this phenotype are not understood. However, in the absence of calreticulin, cells have markedly impaired inositol 1,4,5-trisphosphate (IP 3 ) 1 -dependent Ca 2ϩ release, which prohibits the nuclear translocation of NF-AT in response to Ca 2ϩ stimulation (2) , resulting in the impaired regulation of NF-AT-dependent genes. Calcineurin phosphatase activity is required for nuclear translocation of NF-AT (4, 5) . Calcineurin is a serine/threonine phosphatase, which consists of a catalytic A subunit and a regulatory B subunit (5) . A Ca 2ϩ -and calcineurin B-dependent regulatory region is located in the C-terminal 200 amino acids of the calcineurin A subunit (5) .
Sustained Ca 2ϩ release from the endoplasmic reticulum and Ca 2ϩ influx via the plasma membrane are required to fully activate calcineurin phosphatase activity (5, 6) . Calreticulindeficient cells have impaired IP 3 -dependent Ca 2ϩ release (7) and inhibited nuclear translocation of NF-AT (2), indicating that calcineurin activity is impaired in the absence of calreticulin. Both calreticulin and calcineurin have been implicated in cardiac development and hypertrophy (2, 8) . The elimination of calreticulin in mice causes death in utero because of defective cardiac development (2) , whereas increased activity of calcineurin leads to the development of cardiac hypertrophy (8) . These observations indicate that Ca 2ϩ -and calcineurindependent signaling pathways in the heart may underlie the embryonic lethality displayed by calreticulin-deficient mice. Here we tested this hypothesis and reconstituted the hearts of calreticulin-deficient mice with a truncated constitutively active form of calcineurin to reestablish the Ca 2ϩ -dependent cascade downstream of calreticulin. We show that the overexpression of activated calcineurin reverses the defect in cardiac development observed in calreticulin-deficient mice and rescues them from embryonic lethality.
EXPERIMENTAL PROCEDURES
Transgenic Animals and Histological Analysis-Mice with cardiacspecific expression of activated calcineurin (amino acid residues 1-389) were created using the ␣-MHC promoter (8) . These animals have been extensively characterized (8) . Homozygote transgenic mice with respect to the activated calcineurin transgene were used in all experiments. The creation of calreticulin-deficient mice was described previously (2) . Mice bearing the activated calcineurin transgene (FVB/N strain) were crossed with crt ϩ/Ϫ (C57BL/6J strain) mice. The progeny of this cross were interbred to generate calreticulin-deficient mice expressing activated calcineurin in the heart. The breeding of the transgenic animals was carried out the University of Alberta Health Sciences Transgenic Facility. Histological analysis of cardiac tissue was carried out as described previously (2) . Sections were stained with hematoxylin and eosin.
Calcineurin-dependent Translocation of NF-ATc1-cDNA encoding NF-ATc1 was inserted into the BamH1 site of pEGFP-C1 (Clontech) to * This work was supported by the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Ontario. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Postdoctoral fellow of the Heart and Stroke Foundation of Canada. ¶ Both authors contributed equally to this work. fibroblasts were transiently transfected with the GFP-NF-ATc1 expression vector using Effectene Transfection reagent (Qiagen). The cells were also transfected with pcDNA3.1 plasmids containing cDNA encoding constitutively active calcineurin (activated calcineurin) (10) . As a control, cells were transfected with a pEGFP-C1 with cDNA encoding NF-ATc1 cloned in non-sense orientation. Cells were grown on 25-mm circular coverslips (Fisher Scientific) in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 1% penicillinstreptomycin. Images were captured with a Zeiss Axiovert S100 fluorescent microscope using an excitation wavelength of 490 nm and emission wavelength of 520 nm. All of the pictures were pseudo-colored using Northern Eclipse 5.0 software. Blood Glucose and Serum Lipid Determination-Blood was collected and glucose was measured using Glucometer Elite Blood Glucose Meter (model 3903E, Bayer) with Glucometer Elite blood glucose test strips with 1.1-33.3 mmol/liter sensitivity. Serum total cholesterol and triacyglycerol concentrations were measured using a commercial diagnostic assay (kit number 352 for total cholesterol and kit number 339 for triacylglycerols, respectively, from Sigma).
Miscellaneous-Proteins were separated by SDS-PAGE on 10% polyacrylamide gels as described by Laemmli (11) , transferred to nitrocellulose membranes, and stained by immunoblotting with affinity-purified rabbit anti-calreticulin or anti-calcineurin antibodies (12) . Genomic DNA was isolated from mouse tissue, and the presence of the disrupted calreticulin gene was verified either by Southern blotting or PCR (2). The calcineurin transgene was detected by PCR using the 5Ј primer 5Ј-TATCTCCCCCATAAGAGTTT-3Ј (␣-MHC promoter region) and the 3Ј primer 5Ј-TGATCCCCCAACTTCAAACAACTTCA-3Ј (calcineurin-coding region) using Pfu polymerase. Southern blot analysis was also carried out using the XbaI-SalI (430 bp) DNA fragment derived from pBS-␣-MHC calcineurin plasmid (originally used to generate the transgenic mice) as a probe.
RESULTS AND DISCUSSION
The activation of calcineurin normally requires a sustained Ca 2ϩ release by the IP 3 -dependent pathway (13), but the dele-
Calcineurin-dependent nuclear translocation of NFATc1 in calreticulin-deficient cells. Fibroblasts isolated from calreticulin-deficient and crt ϩ/Ϫ mice were transiently transfected with GFP-NF-ATc1 and the activated calcineurin expression vectors. Localization of GFP-NF-ATc1 was monitored using a Zeiss Axiovert S100 fluorescent microscope with an excitation wavelength of 490 nm and emission wavelength of 520 nm. GFP-NF-ATc1 translocates to the nucleus in the presence of the activated calcineurin. wt, wild type. Bar, 25 m.
FIG. 2. Histological and immunological analysis of the hearts from the calreticulin-deficient embryos.
A, Western blot analysis of proteins from day 17.5 embryonic hearts probed with anti-calcineurin antibodies. Cardiac tissue was isolated from the embryos and homogenized in a buffer containing protease inhibitors (16 tion of the C-terminal 200 amino acid residues from calcineurin yields a fully active and constitutive phosphatase (referred to throughout this paper as ''activated calcineurin'') (10). The functionality of activated calcineurin in the absence of calreticulin was established by analysis of the nuclear translocation of GFP-NF-ATc1, a substrate of calcineurin (5). In the absence of activated calcineurin, GFP-NF-ATc1 did not translocate to the nucleus in wild-type or calreticulin-deficient cells (Fig. 1,  left panels) . However, in the presence of activated calcineurin, GFP-NF-ATc1 rapidly translocated to the nucleus in both cell types (Fig. 1, right panels) . These results demonstrate that activated calcineurin does not require agonist-induced Ca 2ϩ signal and it is fully functional in the absence of calreticulin. Cardiac-specific expression of activated calcineurin was achieved using the ␣-MHC promoter (8), which is transiently active in the embryonic heart and constitutively active after birth (14, 15) . The progeny of this cross were interbred with crt ϩ/Ϫ mice to produce calcineurin transgenic mice that were heterozygous for the inactivated calreticulin allele. The crt ϩ/Ϫ mice expressing activated calcineurin in the heart (designated crt ϩ/Ϫ :activated CaN) were viable and fertile. These mice were crossed to produce calreticulin-deficient mice with active calcineurin in the heart (crt Ϫ/Ϫ :activated CaN). Surprisingly, the expected Mendelian ratios of crt ϩ/ϩ , crt ϩ/Ϫ , and crt Ϫ/Ϫ mice were obtained up to embryonic day (E) 17.5 from serial-timed mating experiments (Table I ). This feature was not evident in calreticulin-deficient mice with normal calcineurin at E14.5 (2, 3) . Western blot analysis with anti-calcineurin antibodies revealed that a low level of endogenous calcineurin was expressed in hearts from wild-type and crt Ϫ/Ϫ E17.5 embryos (Fig. 2A) . Importantly, there was a significant expression of activated (truncated) calcineurin in hearts from crt ϩ/Ϫ :activated CaN and crt Ϫ/Ϫ :activated CaN E17.5 embryos (Fig. 2A ). In agreement with previous reports, the histological analysis of heart from the crt Ϫ/Ϫ embryos revealed deep intertrabecular recesses and increased fenestration associated with the thinner ventricular wall (Fig. 2B) (2, 3) . In stark contrast to the crt Ϫ/Ϫ embryos, the crt Ϫ/Ϫ :activated CaN embryos did not show these defects in cardiac development (Fig. 2B) . Histological analysis of crt ϩ/Ϫ :activated CaN and crt Ϫ/Ϫ :activated CaN embryos showed normal development of the ventricular wall with signs of early hypertrophy probably due to the expression of activated calcineurin (Fig. 2B) . Therefore, we examined whether the overexpression of activated calcineurin permitted the completion of the embryonic program to allow for live birth of crt Ϫ/Ϫ pups. Surprisingly, the crossing of crt ϩ/Ϫ :activated CaN males with crt ϩ/Ϫ :activated CaN females produced live crt Ϫ/Ϫ : activated CaN pups. Thus, full-term development in this mouse strain was no longer dependent on calreticulin. Immunoblot analysis of cardiac tissue taken from 4-week-old crt ϩ/Ϫ :activated CaN and crt Ϫ/Ϫ :activated CaN showed that endogenous calcineurin and activated calcineurin transgene were expressed in the heart in these mice (Fig. 3) . Furthermore, there was a Ͼ15-fold increased expression of activated calcineurin when compared with the endogenous protein. The expression of activated calcineurin was also significantly increased in comparison with expression of the protein in E17.5 embryonic heart. At birth, calreticulin-deficient mice (crt Ϫ/Ϫ :activated CaN) were overtly indistinguishable from their wild-type (crt ϩ/ϩ : activated CaN) and heterozygous (crt ϩ/Ϫ :activated CaN) littermates. However, all of the homozygote calreticulin knock-out mice (crt Ϫ/Ϫ :activated CaN) showed significant growth retardation after the first week of life (Fig. 3) and died 3-5 weeks after birth. Importantly, histological analysis did not show any significant differences in cardiac morphology among crt ϩ/ϩ : activated CaN, crt ϩ/Ϫ :activated CaN, and crt Ϫ/Ϫ :activated CaN mice (Fig. 4) . Cardiac hypertrophy was noted in these mice (Fig. 4) , and this is probably attributable to marked overexpression of activated calcineurin (8) . Remarkably, crt Ϫ/Ϫ : activated CaN mice had a thick ventricular wall comprised of several layers of cardiomyocytes. These observations are in sharp contrast to the severely impaired development of the ventricular wall in the hearts of crt Ϫ/Ϫ -deficient mice as documented in our earlier study (2) . These findings illustrate that the expression of activated calcineurin in calreticulin-deficient hearts is sufficient to restore ventricular development in the absence of calreticulin. Intercrosses between crt ϩ/Ϫ :activated CaN males and crt ϩ/Ϫ :activated CaN females was essential for the rescue. Importantly, homozygote transgenic mice with respect to the activated calcineurin transgene had to be used in all experiments. This is probably because a higher gene dosage of activated CaN was required for efficient rescue of calreticulin-deficient mice. Interestingly, the overexpression of calcineurin and calreticulin are detrimental to normal function of mature heart. High calcineurin phosphatase activity in postnatal hearts leads to hypertrophy and heart failure (8) , and forced expression of calreticulin in newborn heart causes complete heart block and sudden death (16) . The concept that emerges from these studies is that the temporal regulation of calreticulin gene expression is critical for normal heart development and function.
Although expression of activated calcineurin reversed embryonic lethality because of calreticulin deficiency, the surviving mice exhibited postnatal pathology. Of the five crt Ϫ/Ϫ : activated CaN mice born, two died after 5 weeks, two died after 3 weeks, and one died after 1 week. An analysis of blood from crt Ϫ/Ϫ :activated CaN mice indicated hypoglycemia as early as the first week of postnatal life (Fig. 5 ). In addition, the ''milky'' appearance of the serum was indicative of aberrant lipid metabolism. Indeed, biochemical analysis of serum from crt Ϫ/Ϫ : activated CaN mice revealed significantly increased levels of cholesterol (over 4-fold) and triacylglycerols (over 9-fold) (Fig.  5) . The underlying cause for these metabolic aberrations is not yet clear, but the results suggest the importance of calreticulin in the endoplasmic reticulum for normal energy homeostasis after birth.
The remarkable finding in this study is that the reconstitution of the Ca 2ϩ -signaling cascade in crt Ϫ/Ϫ mice with a constitutively active variant of calcineurin permits the proper progression of cardiac development during embryogenesis. These findings support our view that Ca 2ϩ -dependent cardiacspecific transcriptional processes may be impaired in the absence of calreticulin (2) . Studies on cardiac differentiation of calreticulin-deficient embryonic stem cells further support this notion (17) . Cardiomyocytes derived from calreticulin-deficient cells have severely disrupted myofibrillogenesis and impaired nuclear translocation of Mef2c transcription factor (17) . Most importantly, this phenotype can be rescued with Ca 2ϩ ionophore, indicating that specific Ca 2ϩ -dependent pathways essential for cardiac development may not be functional in the absence of calreticulin (17) . Here we show that the expression of activated calcineurin, a Ca 2ϩ -and calmodulin-dependent phosphatase, reverses embryonic lethality in calreticulin-deficient mice. Fig. 6 shows a putative model describing the relationship between calreticulin in the endoplasmic reticulum lumen and calcineurin in the cytoplasm during cardiac development. Under normal physiological conditions, calreticulin is an important Ca 2ϩ storage chaperone in the lumen of the endoplasmic reticulum and is required for agonist-induced IP 3 -dependent Ca 2ϩ release from the endoplasmic reticulum (2, 7). Sustained Ca 2ϩ release from the endoplasmic reticulum is required for the activation of calcineurin and subsequent activation of calcineurin-dependent pathways including transcriptional processes (Fig. 6, left panel) . In the absence of calreticulin, IP 3 -dependent Ca 2ϩ release from the endoplasmic reticulum in response to agonists is severely impaired (2, 7) . Consequently, the endogenous calcineurin may not be fully activated, resulting in the failure to stimulate key Ca 2ϩ -and calcineurin-dependent pathways critical for cardiac development (Fig. 6, middle panel) . In crt Ϫ/Ϫ mice, this defect in Ca 2ϩ signaling manifests in impaired cardiac development, leading to embryonic lethality (2). Our findings suggest that the expression of activated calcineurin bypasses the requirement for agonist-induced InsP 3 -dependent Ca 2ϩ release (2, 7), thereby allowing activation of calcineurin-dependent pathways to occur in the absence of calreticulin (Fig. 6, right panel) . The importance of calreticulin in Ca 2ϩ homeostasis as well as in protein folding and quality control are generally accepted (1) . Here we have demonstrated that calcineurin-dependent pathways are the molecular basis for the rescue of calreticulin-deficient phenotype in mice. Calreticulin is an integral and essential component of cellular Ca 2ϩ homeostasis, and it may be a key upstream regulator of calcineurin function in the Ca 2ϩ signaling cascade.
